{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "32378380", "DateCompleted": {"Year": "2020", "Month": "09", "Day": "23"}, "DateRevised": {"Year": "2024", "Month": "07", "Day": "29"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "1332-8166", "JournalIssue": {"Volume": "61", "Issue": "2", "PubDate": {"Year": "2020", "Month": "Apr", "Day": "30"}}, "Title": "Croatian medical journal", "ISOAbbreviation": "Croat Med J"}, "ArticleTitle": "How to face the aging world - lessons from dementia research.", "Pagination": {"StartPage": "139", "EndPage": "146", "MedlinePgn": "139-146"}, "Abstract": {"AbstractText": ["A continuous rise in life expectancy has led to an increase in the number of senior citizens, now amounting to a fifth of the global population, and to a dramatic increase in the prevalence of diseases of the elderly. This review discusses the threat of dementia, a disease that imposes enormous financial burden on health systems and warrants efficient therapeutic solutions. What we learned from numerous failed clinical trials is that we have to immediately take into account two major elements: early detection of dementia, much before the onset of symptoms, and personalized (precision) medicine treatment approach. We also discuss some of the most promising therapeutic directions, including stem cells, exosomes, electromagnetic fields, and ozone."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dinko Mitre\u010di\u0107, Laboratory for Stem Cells, Croatian Institute for Brain Research, Department of Histology and Embryology, University of Zagreb School of Medicine, \u0160alata 3, 10000 Zagreb, Croatia, dinko.mitrecic@mef.hr."}], "LastName": "Mitre\u010di\u0107", "ForeName": "Dinko", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Petrovi\u0107", "ForeName": "Dra\u017een Juraj", "Initials": "DJ"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Stan\u010din", "ForeName": "Paula", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Isakovi\u0107", "ForeName": "Jasmina", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Zavan", "ForeName": "Barbara", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Tricarico", "ForeName": "Gerardo", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Kujund\u017ei\u0107 Tiljak", "ForeName": "Mirjana", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Di Luca", "ForeName": "Monica", "Initials": "M"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Croatia", "MedlineTA": "Croat Med J", "NlmUniqueID": "9424324", "ISSNLinking": "0353-9504"}, "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": ["physiology"], "DescriptorName": "Aging"}, {"QualifierName": [], "DescriptorName": "Biomedical Research"}, {"QualifierName": ["epidemiology", "physiopathology", "therapy"], "DescriptorName": "Dementia"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["trends"], "DescriptorName": "Life Expectancy"}, {"QualifierName": [], "DescriptorName": "Precision Medicine"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Decade of Healthy Ageing 2020\u20132030. World Health Organization. 2020. p. 1\u201324. Available from: https://www.who.int/docs/default-source/decade-of-healthy-ageing/full-decade-proposal/decade-proposal-fulldraft-en.pdf?sfvrsn=8ad3385d_6. Accessed: April 4, 2020."}, {"Citation": "Life expectancy. Available from: https://ourworldindata.org/grapher/life-expectancy?time=1770.2019&country=OWID_WRL. Accessed: April 4, 2020."}, {"Citation": "Mitre\u010di\u0107 D, Alves-Rodrigues A, Pochet R. A call for unification: How to defragment the human brain, medical professions, and national strategies? Croat Med J. 2019;60:69\u201370. doi: 10.3325/cmj.2019.60.69.", "ArticleIdList": ["10.3325/cmj.2019.60.69", "PMC6509623", "31044577"]}, {"Citation": "Planning for Care Costs Alzheimer\u2019s Association. Available from: https://www.alz.org/help-support/caregiving/financial-legal-planning/planning-for-care-costs. Accessed: April 4, 2020."}, {"Citation": "Cholerton B, Larson EB, Quinn JF, Zabetian CP, Mata IF, Keene CD, et al. Precision medicine: Clarity for the complexity of dementia. Am J Pathol. 2016;186:500\u20136. doi: 10.1016/j.ajpath.2015.12.001.", "ArticleIdList": ["10.1016/j.ajpath.2015.12.001", "PMC4816691", "26724389"]}, {"Citation": "Ferreira LSS, Fernandes CS, Vieira MNN, De Felice FG. Insulin resistance in Alzheimer\u2019s disease. Front Neurosci. 2018;12:830. doi: 10.3389/fnins.2018.00830.", "ArticleIdList": ["10.3389/fnins.2018.00830", "PMC6277874", "30542257"]}, {"Citation": "Hooshmand B, Solomon A, K\u013areholt I, Leivisk\u00e4 J, Rusanen M, Ahtiluoto S, et al. Homocysteine and holotranscobalamin and the risk of Alzheimer disease: A longitudinal study. Neurology. 2010;75:1408\u201314. doi: 10.1212/WNL.0b013e3181f88162.", "ArticleIdList": ["10.1212/WNL.0b013e3181f88162", "20956786"]}, {"Citation": "Kivim\u00e4ki M, Singh-Manoux A, Pentti J, Sabia S, Nyberg ST, Alfredsson L, et al. Physical inactivity, cardiometabolic disease, and risk of dementia: An individual-participant meta-analysis. BMJ. 2019:365.", "ArticleIdList": ["PMC6468884", "30995986"]}, {"Citation": "Lucey BP, McCullough A, Landsness EC, Toedebusch CD, McLeland JS, Zaza AM, et al. Reduced non\u2013rapid eye movement sleep is associated with tau pathology in early Alzheimer\u2019s disease. Sci Transl Med. 2019:11.", "ArticleIdList": ["PMC6342564", "30626715"]}, {"Citation": "Bredesen DE. Inhalational Alzheimer\u2019s disease: An unrecognized-and treatable- epidemic. Aging (Albany NY) 2016;8:304\u201313. doi: 10.18632/aging.100896.", "ArticleIdList": ["10.18632/aging.100896", "PMC4789584", "26870879"]}, {"Citation": "Phillips MCL. Fasting as a therapy in neurological disease. Nutrients. 2019;11:2501. doi: 10.3390/nu11102501.", "ArticleIdList": ["10.3390/nu11102501", "PMC6836141", "31627405"]}, {"Citation": "Bredesen DE. Reversal of cognitive decline: A novel therapeutic program. Aging. 2014;6:707\u201317.", "ArticleIdList": ["PMC4221920", "25324467"]}, {"Citation": "Ngandu T, Lehtisalo J, Solomon A, Lev\u00e4lahti E, Ahtiluoto S, Antikainen R, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet. 2015;385:2255\u201363. doi: 10.1016/S0140-6736(15)60461-5.", "ArticleIdList": ["10.1016/S0140-6736(15)60461-5", "25771249"]}, {"Citation": "Keine D, Walker JQ, Kennedy BK, Sabbagh MN. Development, application, and results from a precision-medicine platform that personalizes multi-modal treatment plans for mild Alzheimer\u2019s disease and at-risk individuals. Curr Aging Sci. 2018;11:173\u201381. doi: 10.2174/1874609811666181019101430.", "ArticleIdList": ["10.2174/1874609811666181019101430", "PMC6388425", "30338750"]}, {"Citation": "Bredesen DE, Amos EC, Canick J, Ackerley M, Raji C, Fiala M, et al. Reversal of cognitive decline in Alzheimer\u2019s disease. Aging (Albany NY) 2016;8:1250\u20138. doi: 10.18632/aging.100981.", "ArticleIdList": ["10.18632/aging.100981", "PMC4931830", "27294343"]}, {"Citation": "Halliday M, Radford H, Zents KAM, Molloy C, Moreno JA, Verity NC, et al. Repurposed drugs targeting eIF2\u03b1-P-mediated translational repression prevent neurodegeneration in mice. Brain. 2017;140:1768\u201383. doi: 10.1093/brain/awx074.", "ArticleIdList": ["10.1093/brain/awx074", "PMC5445255", "28430857"]}, {"Citation": "De Cecco M, Ito T, Petrashen AP, Elias AE, Skvir NJ, Criscione SW, et al. L1 drives IFN in senescent cells and promotes age-associated inflammation. Nature. 2019;566:73\u20138. doi: 10.1038/s41586-018-0784-9.", "ArticleIdList": ["10.1038/s41586-018-0784-9", "PMC6519963", "30728521"]}, {"Citation": "Zhang F, Gannon M, Chen Y, Yan S, Zhang S, Feng W, et al. \u03b2-amyloid redirects norepinephrine signaling to activate the pathogenic GSK3\u03b2/tau cascade. Sci Transl Med. 2020:12.", "ArticleIdList": ["PMC7891768", "31941827"]}, {"Citation": "Mullin S, Smith L, Lee K, D\u2019Souza G, Woodgate P, Elflein J, et al. Ambroxol for the treatment of patients with parkinson disease with and without glucocerebrosidase gene mutations. JAMA Neurol. 2020 doi: 10.1001/jamaneurol.2019.4611. . Epub ahead of print.", "ArticleIdList": ["10.1001/jamaneurol.2019.4611", "PMC6990847", "31930374"]}, {"Citation": "Blennow K, Zetterberg H. Biomarkers for Alzheimer\u2019s disease: current status and prospects for the future. J Intern Med. 2018;284:643\u201363. doi: 10.1111/joim.12816.", "ArticleIdList": ["10.1111/joim.12816", "30051512"]}, {"Citation": "Su\u00e1rez-Calvet M, Morenas-Rodr\u00edguez E, Kleinberger G, Schlepckow K, Araque Caballero M\u00c1, Franzmeier N, et al. Early increase of CSF sTREM2 in Alzheimer\u2019s disease is associated with tau related-neurodegeneration but not with amyloid-\u03b2 pathology. Mol Neurodegener. 2019;14:1. doi: 10.1186/s13024-018-0301-5.", "ArticleIdList": ["10.1186/s13024-018-0301-5", "PMC6327425", "30630532"]}, {"Citation": "Lee JM, Blennow K, Andreasen N, Laterza O, Modur V, Olander J, et al. The brain injury biomarker VLP-1 is increased in the cerebrospinal fluid of Alzheimer disease patients. Clin Chem. 2008;54:1617\u201323. doi: 10.1373/clinchem.2008.104497.", "ArticleIdList": ["10.1373/clinchem.2008.104497", "PMC2672199", "18703769"]}, {"Citation": "H\u00f6glund K, Schussler N, Kvartsberg H, Smailovic U, Brinkmalm G, Liman V, et al. Cerebrospinal fluid neurogranin in an inducible mouse model of neurodegeneration: A translatable marker of synaptic degeneration. Neurobiol Dis. 2020:134.", "ArticleIdList": ["31669672"]}, {"Citation": "Tan X, Luo Y, Pi D, Xia L, Li Z, Tu Q. miR-340 reduces accumulation of amyloid-\u03b2 through targeting BACE1 (\u03b2-site amyloid precursor protein cleaving enzyme 1) in Alzheimer\u2019 s disease. Curr Neurovasc Res. 2020:17.", "ArticleIdList": ["31957613"]}, {"Citation": "Teuber-Hanselmann S, Rekowski J, Vogelgsang J, Von Arnim C, Reetz K, Stang A, et al. CSF and blood kallikrein-8: A promising early biomarker for Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry. 2020;91:40\u20138. doi: 10.1136/jnnp-2019-321073.", "ArticleIdList": ["10.1136/jnnp-2019-321073", "PMC6952834", "31371645"]}, {"Citation": "Ali\u0107 I, Kosi N, Kapuralin K, Gorup D, Gajovi\u0107 S, Pochet R, et al. Neural stem cells from mouse strain Thy1 YFP-16 are a valuable tool to monitor and evaluate neuronal differentiation and morphology. Neurosci Lett. 2016;634:32\u201341. doi: 10.1016/j.neulet.2016.10.001.", "ArticleIdList": ["10.1016/j.neulet.2016.10.001", "27712955"]}, {"Citation": "Konig N, Trolle C, Kapuralin K, Adameyko I, Mitrecic D, Aldskogius H, et al. Murine neural crest stem cells and embryonic stem cell-derived neuron precursors survive and differentiate after transplantation in a model of dorsal root avulsion. J Tissue Eng Regen Med. 2017;11:129\u201337. doi: 10.1002/term.1893.", "ArticleIdList": ["10.1002/term.1893", "24753366"]}, {"Citation": "Mitrecic D, Nicaise C, Klimaschewski L, Gajovic S, Bohl D, Pochet R. Genetically modified stem cells for the treatment of neurological diseases. Front Biosci - Elit. 2012;4:1170\u201381.", "ArticleIdList": ["22201944"]}, {"Citation": "Check My Brain \u2013 Our approach to preventing dementia. Available from: https://check-my-brain.com/. Accessed: April 4, 2020."}, {"Citation": "Kourembanas S. Exosomes: Vehicles of intercellular signaling, biomarkers, and vectors of cell therapy. Annu Rev Physiol. 2015;77:13\u201327. doi: 10.1146/annurev-physiol-021014-071641.", "ArticleIdList": ["10.1146/annurev-physiol-021014-071641", "25293529"]}, {"Citation": "M\u00fcller G. Microvesicles/exosomes as potential novel biomarkers of metabolic diseases. Diabetes Metab Syndr Obes. 2012;5:247\u201382. doi: 10.2147/DMSO.S32923.", "ArticleIdList": ["10.2147/DMSO.S32923", "PMC3422911", "22924003"]}, {"Citation": "Iero M, Valenti R, Huber V, Filipazzi P, Parmiani G, Fais S, et al. Tumour-released exosomes and their implications in cancer immunity. Cell Death Differ. 2008;15:80\u20138. doi: 10.1038/sj.cdd.4402237.", "ArticleIdList": ["10.1038/sj.cdd.4402237", "17932500"]}, {"Citation": "Kalani A, Tyagi A, Tyagi N. Exosomes: Mediators of neurodegeneration, neuroprotection and therapeutics. Mol Neurobiol. 2014;49:590\u2013600. doi: 10.1007/s12035-013-8544-1.", "ArticleIdList": ["10.1007/s12035-013-8544-1", "PMC3951279", "23999871"]}, {"Citation": "Gim\u00e9nez-Llort L, Bl\u00e1zquez G, Ca\u0144ete T, Johansson B, Oddo S, Tobe\u0144a A, et al. Modeling behavioral and neuronal symptoms of Alzheimer\u2019s disease in mice: A role for intraneuronal amyloid. Neurosci Biobehav Rev. 2007;31:125\u201347. doi: 10.1016/j.neubiorev.2006.07.007.", "ArticleIdList": ["10.1016/j.neubiorev.2006.07.007", "17055579"]}, {"Citation": "Kanmert D, Cantlon A, Muratore CR, Jin M, O\u2019Malley TT, Lee G, et al. C-terminally truncated forms of tau, but not full-length tau or its C-terminal fragments, are released from neurons independently of cell death. J Neurosci. 2015;35:10851\u201365. doi: 10.1523/JNEUROSCI.0387-15.2015.", "ArticleIdList": ["10.1523/JNEUROSCI.0387-15.2015", "PMC6605107", "26224867"]}, {"Citation": "Simons M, Raposo G. Exosomes - vesicular carriers for intercellular communication. Curr Opin Cell Biol. 2009;21:575\u201381. doi: 10.1016/j.ceb.2009.03.007.", "ArticleIdList": ["10.1016/j.ceb.2009.03.007", "19442504"]}, {"Citation": "Van Niel G, Porto-Carreiro I, Simoes S, Raposo G. Exosomes: A common pathway for a specialized function. J Biochem. 2006;140:13\u201321. doi: 10.1093/jb/mvj128.", "ArticleIdList": ["10.1093/jb/mvj128", "16877764"]}, {"Citation": "Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJA. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011;29:341\u20135. doi: 10.1038/nbt.1807.", "ArticleIdList": ["10.1038/nbt.1807", "21423189"]}, {"Citation": "Isakovic J, Dobbs-Dixon I, Chaudhury D, Mitrecic D. Modeling of inhomogeneous electromagnetic fields in the nervous system: a novel paradigm in understanding cell interactions, disease etiology and therapy. Sci Rep. 2018:8.", "ArticleIdList": ["PMC6110729", "30150694"]}, {"Citation": "Lefaucheur JP, Andr\u00e9-Obadia N, Antal A, Ayache SS, Baeken C, Benninger DH, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clin Neurophysiol. 2014;125:2150\u2013206. doi: 10.1016/j.clinph.2014.05.021.", "ArticleIdList": ["10.1016/j.clinph.2014.05.021", "25034472"]}, {"Citation": "Hayashi T, Ohnishi T, Okabe S, Teramoto N, Nonaka Y, Watabe H, et al. Long-term effect of motor cortical repetitive transcranial magnetic stimulation induces. Ann Neurol. 2004;56:77\u201385. doi: 10.1002/ana.20151.", "ArticleIdList": ["10.1002/ana.20151", "15236404"]}, {"Citation": "Liao X, Li G, Wang A, Liu T, Feng S, Guo Z, et al. Repetitive transcranial magnetic stimulation as an alternative therapy for cognitive impairment in Alzheimer\u2019s disease: A meta-analysis. J Alzheimers Dis. 2015;48:463\u201372. doi: 10.3233/JAD-150346.", "ArticleIdList": ["10.3233/JAD-150346", "26402010"]}, {"Citation": "Nardone R, Tezzon F, H\u00f6ller Y, Golaszewski S, Trinka E, Brigo F. Transcranial magnetic stimulation (TMS)/repetitive TMS in mild cognitive impairment and Alzheimer\u2019s disease. Acta Neurol Scand. 2014;129:351\u201366. doi: 10.1111/ane.12223.", "ArticleIdList": ["10.1111/ane.12223", "24506061"]}, {"Citation": "Stagg CJ, Nitsche MA. Physiological basis of transcranial direct current stimulation. Vol. 17. Neuroscientist. 2011: 37\u201353. doi: 10.1177/1073858410386614.", "ArticleIdList": ["10.1177/1073858410386614", "21343407"]}, {"Citation": "Liebetanz D. Pharmacological approach to the mechanisms of transcranial DC-stimulation-induced after-effects of human motor cortex excitability. Brain. 2002;125:2238\u201347. doi: 10.1093/brain/awf238.", "ArticleIdList": ["10.1093/brain/awf238", "12244081"]}, {"Citation": "Arendash GW, Sanchez-Ramos J, Mori T, Mamcarz M, Lin X, Runfeldt M, et al. Electromagnetic field treatment protects against and reverses cognitive impairment in Alzheimer\u2019s disease mice. J Alzheimers Dis. 2010;19:191\u2013210. doi: 10.3233/JAD-2010-1228.", "ArticleIdList": ["10.3233/JAD-2010-1228", "20061638"]}, {"Citation": "Isakovi\u0107 J, Gorup D, Mitre\u010di\u0107 D. Molecular mechanisms of microglia- and astrocyte-driven neurorestoration triggered by application of electromagnetic fields. Croat Med J. 2019;60:127\u201340. doi: 10.3325/cmj.2019.60.127.", "ArticleIdList": ["10.3325/cmj.2019.60.127", "PMC6509634", "31044584"]}, {"Citation": "Kuhn J, Hardenacke K, Lenartz D, Gruendler T, Ullsperger M, Bartsch C, et al. Deep brain stimulation of the nucleus basalis of Meynert in Alzheimer\u2019s dementia. Mol Psychiatry. 2015;20:353\u201360. doi: 10.1038/mp.2014.32.", "ArticleIdList": ["10.1038/mp.2014.32", "24798585"]}, {"Citation": "Laxton AW, Tang-Wai DF, McAndrews MP, Zumsteg D, Wennberg R, Keren R, et al. A phase i trial of deep brain stimulation of memory circuits in Alzheimer\u2019s disease. Ann Neurol. 2010;68:521\u201334. doi: 10.1002/ana.22089.", "ArticleIdList": ["10.1002/ana.22089", "20687206"]}, {"Citation": "Capelli E, Torrisi F, Venturini L, Granato M, Fassina L, Lupo GFD, et al. Low-frequency pulsed electromagnetic field is able to modulate miRNAs in an experimental cell model of Alzheimer\u2019s disease J Healthc Eng 2017. 201710.1155/2017/2530270", "ArticleIdList": ["10.1155/2017/2530270", "29072895"]}, {"Citation": "Jeong Y, Kang G-Y, Kwon J, Choi H-D, Pack J-K, Kim N, et al. 1950 MHz Electromagnetic Fields Ameliorate A\u03b2 Pathology in Alzheimer\u2019s Disease Mice. Curr Alzheimer Res. 2015;12:481\u201392. doi: 10.2174/156720501205150526114448.", "ArticleIdList": ["10.2174/156720501205150526114448", "PMC5445699", "26017559"]}, {"Citation": "Mokhov NV, Van Ginneken A. Muons versus hadrons for radiotherapy. Proceedings of the IEEE Particle Accelerator Conference. 1999:2525\u20137."}, {"Citation": "Bossoni L, Grand Moursel L, Bulk M, Simon BG, Webb A, Van Der Weerd L, et al. Human-brain ferritin studied by muon spin rotation: A pilot study. J Phys Condens Matter. 2017: 29.", "ArticleIdList": ["28872048"]}, {"Citation": "Bocci V. Ozone: A new medical drug. Springer; 2011."}, {"Citation": "Domb WC. Ozone therapy in dentistry: A brief review for physicians. Interv Neuroradiol. 2014;20:632\u20136. doi: 10.15274/INR-2014-10083.", "ArticleIdList": ["10.15274/INR-2014-10083", "PMC4243235", "25363268"]}, {"Citation": "Amin LE. Biological assessment of ozone therapy on experimental oral candidiasis in immunosuppressed rats. Biochem Biophys Rep. 2018;15:57\u201360.", "ArticleIdList": ["PMC6067064", "30069501"]}, {"Citation": "Lin SY, Ma J, An JX, Qian XY, Wang Y, Cope DK, et al. Ozone Inhibits APP/A\u03b2 Production and Improves Cognition in an APP/PS1 Transgenic Mouse Model. Neuroscience. 2019;418:110\u201321. doi: 10.1016/j.neuroscience.2019.07.027.", "ArticleIdList": ["10.1016/j.neuroscience.2019.07.027", "31349006"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "5", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "5", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "9", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "4", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32378380", "PMC7230408", "10.3325/cmj.2020.61.139"]}}], "PubmedBookArticle": []}